Abstract

Background: Histone acetylation modification has been found to be correlated the development of renal carcinoma; however, its role in clear cell renal carcinoma (ccRCC) remains to be investigated. Thus, this study aimed to identify the molecular subtypes and establish a relevant score based on histone acetylation modification in ccRCC.Methods: Gene expression and mutation data were retrieved from The Cancer Genome Atlas database. Molecular subtypes were identified by unsupervised clustering based on histone acetylation regulators expression, and the molecular and clinical characteristics including survival, tumor microenvironment, gene set variation, immune cell infiltration, and immune checkpoints in each subtype were investigated. Next, we employed univariate Cox analysis to analyze these genes and established acetylation-related score by lasso regression analysis. Furthermore, we investigated the differences including survival, signaling pathways, mutational landscape, and tumor mutation burden (TMB) between high-risk and low-risk groups. The established score was validated by receiver operating curve and univariate and multivariate Cox regression analyses. We also established a nomogram including acetylation score, age, gender, grade, and stage and verified it by decision curve analysis and calibration plot. The E-MTAB-1980 cohort from the ArrayExpress database was employed as a reference to validate the established score.Results: Thirty-three types of histone acetylation regulators were employed in this study, and two clusters were identified. The two clusters presented significant differences in survival, tumor microenvironment, immune cell infiltration, immune checkpoints, and signaling pathways. Furthermore, an acetylation-related score, composed of six genes (BRD9, HDAC10, KAT2A, KAT5, BRDT, SIRT1, KAT6A, HDAC5), was verified to be significantly associated with prognosis and TMB. Thus, the established scores were successfully verified by the validated cohort, and the nomogram was constructed and successfully validated.Conclusion: The identification of the histone acetylation-related subtypes and score in our study may help reveal the potential relation between histone acetylation and immunity and provide novel insights for the development of individualized therapy for ccRCC.

Highlights

  • As one of the most common malignant urological tumors, renal cell carcinoma (RCC) accounts for approximately 2–3% of adult tumors and 90% of kidney cancers (Moch et al, 2016)

  • The imbalance and cross-talk among 33 acetylationrelated genes are observed in our results, which verifies that histone acetylation modification plays a crucial role in clear cell renal carcinoma (ccRCC)

  • In terms of immune checkpoints, different clusters show various expression levels of immune checkpoints, but we found that no pair of receptor and ligand was significantly expressed in the same cluster, so the correlation between histone acetylation modification and immunotherapy in ccRCC needs further validation

Read more

Summary

Introduction

As one of the most common malignant urological tumors, renal cell carcinoma (RCC) accounts for approximately 2–3% of adult tumors and 90% of kidney cancers (Moch et al, 2016). According to the pathologic classification, RCC is generally divided into four pathological subtypes: clear cell renal carcinoma (ccRCC), granulosa cell renal carcinoma, mixed cell renal carcinoma, and undifferentiated cell renal carcinoma. CcRCC is the major subtype in RCC, which accounts for 70–80% (Moch et al, 2016). The molecular targeted therapy presents the remarkable curative effectiveness in advanced ccRCC, the drug response rate and obvious side effect limits the clinical benefit (Siegel et al, 2020). The investigation and development of prognostic biomarkers are urgently needed in ccRCC. Histone acetylation modification has been found to be correlated the development of renal carcinoma; its role in clear cell renal carcinoma (ccRCC) remains to be investigated. This study aimed to identify the molecular subtypes and establish a relevant score based on histone acetylation modification in ccRCC

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call